Corallopyronin A is a promising in vivo active antibiotic, currently undergoing preclinical evaluation. This myxobacterial compound interferes with a newly identified drug target site, i.e., the switch region of the bacterial DNA-dependent RNA-polymerase (RNAP). Since this target site differs from that of known RNAP inhibitors such as the rifamycins, corallopyronin A shows no cross-resistance with other antibacterial agents. Corallopyronin A is a polyketide synthase-and nonribosomal peptide synthetase-derived molecule whose structure and biosynthesis is distinguished by several peculiarities, such as the unusual vinyl carbamate functionality whose formation involves carbonic acid as an unprecedented C1-starter unit. Using in vitro experiments the nature of this starter molecule was revealed to be the methyl ester of carbonic acid. Biochemical investigations showed that methylation of carbonic acid is performed by the O-methyltransferase CorH. These experiments shed light on the biosynthesis of the Eastern chain of ␣-pyrone antibiotics such as corallopyronin A.
A ntibiotics are one of the major factors that have increased the life expectancy of humans. However, due to the increasing global spread of antibacterial resistance, most antibiotics lose their power, a fact which represents a tremendous health threat. Therefore, the search for antibiotically active compounds has been intensified, and natural products are of utmost importance as new drug molecules and lead structures. Spore-forming soil bacteria with a complex lifestyle, e.g., bacilli, streptomycetes, and myxobacteria, have proved to be a good source for such compounds.
Corallopyronin A is produced by strains of Corallococcus coralloides, a gliding and fruiting body-forming myxobacterium. Originally identified as an antibacterial substance in the 1980s (1), we recently gained some insights into the biosynthesis of corallopyronin A (2) . The mechanistic basis of its antibiotic activity as a noncompetitive inhibitor of the bacterial DNA-dependent RNA polymerase (RNAP) has been investigated (3, 4) . The molecule inhibits RNAP by binding to a pocket inside of the holo-enzyme and thereby interferes with RNA synthesis. RNAP is a proven target for antibacterial treatment, i.e., rifamycins are in clinical use for the treatment of tuberculosis. Corallopyronin A has no crossresistance toward rifamycins, since it occupies a different binding site (3, 4) . Corallopyronin A is active against many Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus, but is most promising against infections in which intracellular bacteria are involved, i.e., in vivo activity against Wolbachia, the obligate endosymbionts of filarial nematodes was proven by us (5) . Targeting these bacteria was shown to be a good approach to control filarial infections, which cause elephantiasis and river blindness (6, 7) , the latter being leading causes of morbidity in developing countries. For the development of further antibiotics detailed investigation of the interactions between the RNAP and its different inhibitors is important, especially when considering the quick development of resistance against RNAP inhibitors (8) . The aim of the present study is thus to investigate in detail the biosynthesis of the RNAP-inhibitor corallopyronin A, in order to enable us to use bioengineering for the structural modification of the target molecule.
In general, modification of the corallopyronin A structure may be achieved by different approaches, e.g., genetic modification of the biosynthetic gene cluster or directed precursor feeding to the producing organism, and in this way exploiting the flexibility of biosynthetic enzymes. Corallopyronin A is synthesized by a multienzyme complex that is a combination of a polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS). In general, this type of enzyme is well characterized and acts in a modular way, combining key biochemical steps in an assembly line fashion to create structural diversity (9) . The biosynthesis of corallopyronin A, however, is atypical and has several peculiarities. The molecule is synthesized from two separate chains (eastern and western chains), which are finally intermolecularly connected to form the precursor, i.e., precorallopyronin A, of the active compound. The starter molecule of the eastern chain is hypothesized to be carbonic acid, which becomes methylated and subsequently is elongated by a glycine moiety and three acetate units. In that way, the most unusual vinyl carbamate functionality is formed by the mixed NRPS-PKS system involved. This assumption was based on the domain order of the biosynthetic enzymes and on the feeding experiments with labeled precursors, i.e., acetate, bicarbonate, glycine, and S-adenosylmethionine (SAM). The incorporation of these precursors into the final molecule was clearly proven. Formation of the methyl ester was suggested to involve the O-methyltransferase CorH (2). We investigate in the present study this putative O-methyltransferase and the attachment of carbonic acid methyl ester at the acyl carrier protein (ACP), i.e., ACP1 of the loading module of the corallopyronin A assembly line. The western chain is solely PKS derived and, with the exception of the two methyl groups in the ␤ position, which are introduced by a specific ␤-branching cassette encoded in the gene cluster (2), its assembly follows the classical colinearity rule (10) . However, the enzymes involved in the assembly of the western chain have been hypothesized to show a certain degree of flexibility, since the derivative corallopyronin B was detected in fermentation broth (11) , whereby the latter might be based on a different building block incorporated, i.e., propionyl-CoA (propionyl coenzyme A) instead of acetyl-CoA.
MATERIALS AND METHODS
Strains and plasmids. Escherichia coli strains were cultured in Luria-Bertani (LB) medium at 37°C, if not otherwise specified, which was supplemented with antibiotics if necessary to select and maintain plasmids (ampicillin, 100 g/ml; kanamycin, 60 g/ml Genomic DNA of C. coralloides B035 was isolated with a Wizard Genomic DNA purification kit (Promega) according to the manufacturer's instructions. This DNA served as the PCR template for the amplification of the 5= part of the corI gene to obtain an ACP1-containing fragment. Using a proofreading polymerase with the primer pair dn_ACP1_TOPO (5=-CTAGACGAGCCGCAGCGCATAG-3=) and up_ACP1_TOPO (5=-C ACCATGAGCACGCAGGGGAC-3=), a PCR product of 1,432 bp was amplified and subsequently purified by agarose gel chromatography. The DNA band was cut out and extracted using the Wizard SV gel and PCR clean-up system (Promega). This was introduced in the vector pET151 TOPO (Invitrogen) by topoisomerase cloning. Transformation of competent E. coli cells with this mixture followed, and ampicillin resistant clones were selected. The plasmid pET151ϩACP1 was isolated and subsequently transferred into the expression host E. coli Bap-1.
For the construction of the expression plasmid for corH, the CorHcoding sequence was submitted to the online tool GeneOptimizer, which is embedded in the pipeline for gene synthesis by GeneArt (Invitrogen). The codon usage of the gene was optimized for E. coli as an expression host, and the recognition sites for the restriction enzymes EcoRI and HindIII were introduced upstream and downstream of the gene, respectively. Using these restriction sites, the gene was excised from the original plasmid, gel purified, and subsequently ligated into the likewise-restricted expression vector pET28, yielding plasmid pET28CorH*. The identity of the introduced CorH-coding sequence was verified by sequencing. We used E. coli BL21 as the expression host. The DNA sequence of the corallopyronin A biosynthetic gene cluster of C. coralloides B035 is available under GenBank accession number HM071004.
Protein expression and purification. For the expression of the proteins, a preculture of the respective E. coli clone was inoculated in 9 ml of LB medium with antibiotic selection overnight at 37°C. This preculture was used to inoculate the main culture (1 liter) of the same medium. Incubation was performed at 37°C until an optical density at 600 nm (OD 600 ) of 0.5 was reached. The culture was then cooled to 16°C and induced with IPTG (isopropyl-␤-D-thiogalactopyranoside) at a final concentration of 0.5 mM, and incubation was carried on for 16 h. Cells were harvested by centrifugation, resuspended in lysis buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 10 mM imidazole [pH 8.0]), and transferred to 50-ml Falcon tubes. The cells were then disrupted by sonication (six cycles for 10 pulses, with cooling on ice between the cycles). After sonification, the cell debris was removed by centrifugation for 30 to 45 min at 8,500 rpm at 4°C. The protein containing supernatant was transferred onto gravity flow columns (Qiagen), which were packed before with 1 ml of Ni-NTA agarose. To increase the amount of bound His-tagged protein, the flowthrough was collected and back-loaded onto the same column (this reloading step was performed three times). The column was then washed twice with washing buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 20 mM imidazole [pH 8.0]). Afterward, the bound protein was eluted five times with 500 l of elution buffers (50 mM NaH 2 PO 4 , 300 mM NaCl [pH 8.0], and stepwise increasing imidazole concentrations: once at 100 mM, once at 150 mM, once at 200 mM, and twice at 300 mM). The fractions containing the targeted protein were combined and loaded onto a spin filter column (Millipore, 10-kDa exclusion size) for desalting. This column was centrifuged at 4°C until only one-tenth of the starting volume remained. The proteins were rebuffered in 50 mM Tris buffer (pH 8.0), concentrated as described above, and again buffered in 50 mM Tris buffer (pH 8.0). Proteins were either used fresh or 10% glycerol was added before shock freezing with liquid nitrogen to store the proteins at Ϫ80°C.
ACP1 loading assay. Purified ACP1 protein solution was supplemented with 100 l of cell lysate, which was prepared as follows. A 100-ml culture of C. coralloides B035 was grown in MD1ϩG medium for 2 days at 30°C, before the cells were harvested by centrifugation. The cell pellet was resuspended in 5 ml of lysis buffer (as described in protein expression and purification) and cells were broken by ultrasonic treatment. This crude extract was centrifuged for 30 to 45 min at 10,000 ϫ g and 4°C. The supernatant was directly applied as cell lysate in the assay, and incubation was performed for 70 min at 30°C. To desalt and purify the protein sample, the assay mixture was directly subjected to semi preparative RP-HPLC (a C4 reversed-phase column [Symmetry 300], 5 M, 4.6 by 250 mm, Waters; eluent, water, 0.5% trifluoroacetic acid-acetonitrile; gradient, 70/30 to 35/65 over 30 min; flow rate, 1.0 ml/min). The protein fraction was manually collected and dried in a SpeedVac concentrator (see Fig. S1 in the supplemental material).
The dried samples were dissolved in an adequate volume of electrospray solution (49.5% H 2 O, 49.5% methanol, 1% formic acid). Next, 20-l samples were loaded onto the 96-well plate of the NanoMate spray robot coupled to the LTQ Orbitrap Velos. A spray chip with a 5-m nozzle diameter was used at a spray voltage of 1.6 kV and a 0.3-lb/in 2 pressure setting. An environmental polysiloxane ion with m/z 445.12003 was used as a lock mass for internal calibration. Isolation and fragmentation were performed in the linear ion trap; detection of the final product spectrum was done with the Orbitrap analyzer. The ejection ions were obtained by in source fragmentation, applying 50 to 65 V of fragmentation energy. The resulting ejection ions were isolated and subjected to further rounds of fragmentation to ensure that these ions were indeed phosphopantetheine (PPant) ejection ions tethered with substrate. A next round of fragmentation (MS 3 ) yielded the expected PPant arm (calculated, m/z 216.1267; measured, m/z 216.1277), which could be further fragmented (MS 4 ) and revealed the expected PPant signature ions (12) . O-Methyltransferase assay. A typical assay consisted of 10 to 50 l of enzyme solution, 10 l of MgCl 2 (25 mM), 10 l of substrate (100 mM), and Tris buffer (50 mM, pH 8.0) and was started by adding 1 l of 50 mM SAM in a final volume of 100 l. An assay without a substrate served as a negative control to determine the blank value. The assay was stopped by adding 100 l of methanol and could be stored at 4°C. The sample was pelleted in a table-top centrifuge (15 min, 17,000 ϫ g), and the supernatant was transferred to a new vial and dried in a SpeedVac concentrator. The analysis of the O-methyltransferase activity was performed by a coupled S-adenosine-homocysteine hydrolase assay as previously described (11) and was read out by a microplate reader (Sunrise-Basic Tecan; extinction measured at 412 nm). The values represent endpoint measurements after 26 h of incubation at 30°C. The mean value of two independent protein purifications (1 liter of culture volume) is given.
RESULTS
Loading of methylated hydrogen carbonate onto ACP1. Biosynthesis of the eastern chain of the corallopyronin A (Fig. 1 ) was predicted to use carbonic acid or its monomethyl ester as the starter molecule (2) . To experimentally verify this hypothesis, the expression of the first acyl carrier protein (ACP1) domain of the biosynthetic gene cluster was projected. Therefore, the 5= part of the corI gene was amplified by PCR with specific primers, yielding a PCR product of 1,432 bp. The usage of a proofreading polymerase for the PCR enabled the following topoisomerase-dependent cloning reaction in the expression vector pET151. The identity of the ACP1-coding fragment was verified by sequencing, before the expression construct pET151-ACP1 was transferred to E. coli Bap-1 cells. This strain harbors a genomic integrated copy of the Sfp-coding sequence from Bacillus subtilis (12) . This sequence codes for a phosphopantetheine (PPant) transferase that shows broad substrate flexibility and, in that way, the apo-ACP1 is directly transformed to the holo-protein carrying the PPant arm, to which the substrates will be attached. After expression and purification, the ACP1 holo-protein was incubated with freshly prepared crude protein extract from strain C. coralloides B035, which was grown for 48 h, a time frame in which corallopyronin A production was always observed (unpublished results). Incubation was performed for 70 min at 30°C. Longer incubation times resulted in protein degradation. The ACP1 protein treated in that way was desalted and purified by high-pressure liquid chromatography (HPLC). After the ACP1-containing fraction was dried, analysis was performed by electrospray ionization-mass spec- trometry. Applying the PPant ejection assay made it possible to identify substrates loaded onto holo-ACP1. Collision energy in the linear ion trap applied to such a holo-protein resulted in the ejection of the PPant residue. If a substrate is tethered to this PPant arm, ejection ions will consist of PPantϩsubstrate (13) (14) (15) . A further round of fragmentation clarifies whether the isolated ejection ion is indeed a PPant-containing molecule, since specific signature ions, corresponding to the PPant residue, can be used for the identification. For the ACP1 holo-protein incubated with crude extract from C. coralloides B035, an ejection ion (MS 2 ) was identified, whose m/z (319.13, isolation width 1) corresponded to methylated hydrogen carbonate tethered to the PPant arm (calculated m/z, 319.13) (see Fig. S2 and S3 in the supplemental material). This clearly proved the nature of the parent ejection ion as loaded onto the PPant arm, and evidence was gained that the predicted unusual building block is indeed methylated hydrogen carbonate, acting as the starter molecule by priming the loading module for corallopyronin A biosynthesis.
Analysis of the SAM-dependent O-methyltransferase CorH. The analysis of the ACP1-bound starter molecule of corallopyronin A biosynthesis indicated that the O-methylation reaction of the C1-building block takes place before the starter unit is tethered to the PKS machinery, since unmethylated carbonic acid was not detected. The putative candidate for this methylation reaction was CorH, showing, according to bioinformatics analysis, a similarity to O-methyltransferases (MTs). MTs are often found as domains within the PKS machinery and act on the growing intermediate or are clustered with the PKS genes and code for enzymes catalyzing so-called post-PKS reactions on the molecule backbone built by the PKS core enzymes (16) . The latter seemed to be the case for CorH, whose gene corH is encoded directly upstream of corI. CorH, however, seems to act on a precursor molecule prior polyketide assembly.
Comparison of the amino acid sequence encoded by corH with proteins found in databases in a protein BLAST search revealed some sequence identity with putative SAM-dependent MTs from mycobacterial species (identity, ϳ35%). MelK, an MT from Melittangium lichenicola (17, 18) showing 27% identity toward CorH, was the first hit in the group of the deltaproteobacteria and is catalyzing an O methylation in the biosynthesis of myxothiazol, also a myxobacterial PKS-NRPS-derived antibiotic.
The signature sequences for SAM binding were difficult to identify in CorH and for related sequences such as those in MelK.
However, a deeper analysis of the CorH sequence revealed conserved motifs that are predicted to contribute to SAM binding. In comparison to the biochemically investigated human brain protein phosphatase 2A leucine carboxyl methyltransferase (LCMT) (19) , and with MelK, both MTs use SAM as a cofactor, the binding motifs I to III could be detected (Fig. 2) . These regions coincide with the conserved motifs identified and predicted to contribute to SAM binding (20) . Thus, it can be expected that CorH, like MelK and LCMT, binds the cofactor SAM in a similar way as other MTs, as judged from the presence of the typical SAM binding fold.
To support experimentally the proposed function of CorH as an MT involved in the formation of the starter, its heterologous expression in E. coli was projected. However, all attempts to express and purify CorH as a His tag, a His-Asn tag, or a streptavidin tag fusion protein failed, since the expression level was too low. For that reason, a synthetic gene was finally used, whose codon usage was optimized for the heterologous host E. coli. Therefore, the tool GeneOptimizer was used, which is embedded in the pipeline for gene synthesis by GeneArt. The codon usage optimized gene was constructed with introduced EcoRI and HindIII restriction sites. By using these restriction sites, the gene was excised from the original plasmid, gel purified, and subsequently ligated into the likewise-restricted expression vector pET28, yielding plasmid pET28CorH*.
A second obstacle which had to be overcome to biochemically characterize CorH was that standard HPLC-based assays, such as HPLC coupled with a diode array detector, could not be used since hydrogen carbonate shows no absorbance. Therefore, a newly developed assay, which couples the activity of S-adenosylhomocysteine (SAH) hydrolase to the SAM-dependent methylation reaction, was used (11) . By applying this approach, the methylation activity could be determined indirectly by measuring the amount of SAM consumed. To avoid the inclusion of nonspecific SAM consumption through any remaining activity from contaminating E. coli proteins, additional controls had to be made. Indeed, in negative controls without enzyme, the methylation activity was zero, but in control reactions with enzyme and without substrate, SAH was detectable. This value was subtracted to set the basal background activity to zero. In that way, the remaining activity could then be assigned to CorH and the consumed substrate. Using this assay, CorH activity toward the expected substrate hydrogen carbonate was proven. To test the activity of CorH toward other substrates presenting a hydroxyl group, glycerol and isovanillinic acid were applied. Only with glycerol, which presents three hydroxyl groups accessible for methylation, was activity detected. However, under the prevailing conditions, the methylating activity was very low. After 26 h of incubation at 30°C, 25.7 M SAM was used to methylate HCO 3 Ϫ and 19.5 M was used to methylate glycerol. Further, the enzyme proved itself to be very heat sensitive, and activity was detected at 30°C but, unexpectedly, no activity remained in samples incubated at 37°C.
DISCUSSION
Thus far, all isolated derivatives of corallopyronin and the structurally related myxopyronins have shown no alteration on the eastern chain and start with the unusual vinyl carbamate functionality. While the present report was under review, Sucipto et al. reported a gene knockout experiment for the myxopyronin producer, the genetically accessible strain Myxococcus fulvus Mxf50. In this strain, the corH homologue myxH was deleted, resulting in a complete abolishment of myxopyronin A production (21), thereby proving this methyltransferase, i.e., MyxH and CorH, to be enzymes essential for biosynthesis of these antibiotics. Feeding studies with labeled precursors for corallopyronin A biosynthesis revealed SAM and sodium bicarbonate as constituent parts of this moiety (2) . Therefore, the biosynthetic hypothesis was that carbonic acid or, more plausibly, its more stable monomethyl ester is the first building block loaded onto the PKS-NRPS assembly line. Usually, building blocks have to be present as coenzyme A (CoA) esters and are loaded by the catalytic activity of acyl transferases. However, no such enzyme is encoded within the biosynthetic gene cluster for corallopyronin A, although such an enzyme encoded elsewhere in the C. coralloides B035 genome might be responsible. Another possibility is the self-loading of the substrate, as has already described for other ACPs (22) . PKS substrates are in general activated by CoA or, in the case of (amino) acids, activation is achieved by phosphate groups that enable subsequent loading onto the NRPS carrier protein domains. Such a mechanism can also be expected for the incorporation of hydrogen carbonate, whereby we suspect that first a phosphate group from ATP may be transferred to HCO 3 Ϫ to give carbonyl phosphate. This would mean that HCO 3 Ϫ connected with an activating group rather than the free molecule would represent the natural substrate, accessible to O methylation by CorH. That could explain the low activity of CorH in the performed assays, whereby sodium bicarbonate which dissolves into free HCO 3 Ϫ was used. The instability of CorH at increased temperatures, i.e., activity was unexpectedly completely abolished at 37°C, reflects the growth optimum of the antibiotic-producing strain at 30°C. This is in contrast to other investigated MTs that show higher temperature optima before an activity decrease takes place, e.g., the maximal activities of MycE and MycF, two MTs involved in the biosynthesis of mycinamicin macrolid antibiotics, were observed at 50 and 37°C, respectively (23) .
The successful methylation of HCO 3 Ϫ by CorH through SAM consumption is in agreement with feeding studies performed earlier, which clearly showed SAM to be the methyl group donor (2). Thus, here the assumed involvement of CorH in allocation of a precursor for corallopyronin A biosynthesis was verified. It can further be assumed that binding to an activating group such as, e.g., phosphate, and methylation are early events to get a more stable precursor available for the biosynthesis (Fig. 3) , since free HCO 3 Ϫ is in equilibrium with CO 2 , which is volatile. Experiments with ACP1 showed that the concentration and stability of the precursor, which initiates corallopyronin A biosynthesis, is indeed high enough in C. coralloides B035 cells to enable loading of the carrier protein by incubation with cell lysate. Whether the precursor is methylated hydrogen carbonate itself or its phosphate ester cannot be judged from our experiments.
The first carrier protein ACP1 of corallopyronin A biosynthesis is either loaded by a transferase-like enzyme or by self-loading, whereby in each case the precursor is specifically picked out of the cell lysate. trans-Acyl transferases (trans-ATs) show a preference for specific activated building blocks which they load to the corresponding ACPs. By specific interaction of ACPs and ATs, the recognition and loading of the correct substrate is assured (24) . In the corallopyronin A gene cluster, only one trans-AT is encoded, yielding methylated hydrogen carbonate. This is the precursor which gets in the following loaded to the carrier protein of the loading module (ACP1) of the mixed trans-PKS-NRPS enzymatic machinery of corallopyronin A biosynthesis. After tethering of several more building blocks, e.g., acetate, glycine, and SAM, the eastern chain is completed at the carrier protein of module 6 (ACP6). By head-to-head condensation with the western chain, which is bound to the carrier protein of module 7= (ACP7=), the corallopyronin A backbone was built. Further processing (post-PKS reactions) finally yields corallopyronin A.
i.e., in corA, that is suspected to be responsible for the loading of the malonyl-CoA units to the respective modules. Thus, it is more likely that CorA is not involved in the loading of the unusual starter unit; rather, a self-loading mechanism might be the case. For carrier domains of NRPSs, it has been shown that they are able to select the correct substrate from complex mixtures (25) . However, to a small extent, additional unspecific loading of ACPs in NRPSs has been demonstrated to occur within such experiments (24) . In addition to these observations, unspecific loading of ubiquitous CoA derivatives was found for expressed holo-carrier proteins (15) . In these cases, ejection ions with an m/z of 303 were observed (15) , corresponding to a loaded acetyl moiety. In the case of ACP1, no such acetylated variant was detectable. However, by scanning for a PPant signature, a second ejection ion with m/z 359 (isolation width 1) could be isolated, representing most probably an unspecific loading with a CoA derivative arising from fatty acid metabolism (see supporting information and Fig. S4 in the supplemental material). Usually, such wrongly loaded building blocks do not appear in the final products of PKS-NRPS assembly lines, since the downstream following domains fulfill gatekeeper functions and terminate the process.
The assembling enzymes for the western chain seem to accept different precursor molecules, resulting in two derivatives with an altered chain length, namely, corallopyronins A and B. Both show good antimicrobial activities, whereby the activity of the major metabolite corallopyronin A outcompetes corallopyronin B (MICs of 0.097 g/ml versus 0.39 g/ml toward Staphylococcus aureus) (1) . It can be assumed that the basis for this difference in the MICs is that corallopyronin A fits better into the binding pocket of the antibiotic within the switch region of the RNAP. This would be in accordance with the fact that the antibacterial activity increases from the structural comparable myxopyronin A to myxopyronin B to corallopyronin A with the increasing length of the western chain (MICs of 1, 0.3, and 0.097 g/ml, respectively, toward S. aureus) (1). It seems as though the available space within the hydrophobic pocket is optimally occupied by corallopyronin A (5), and even slight elongation by one carbon atom, as in corallopyronin B, results in a repulsion reduced fit to the target structure.
In conclusion, we provide experimental proof for the recruitment of the unusual building block hydrogen carbonate in corallopyronin A biosynthesis. The latter is methylated by the MT CorH and loaded onto ACP1 of the corallopyronin A assembly line. This knowledge on a unique feature of a biosynthetic machinery responsible for antibiotic production provides the basis for future genetic combinatorial engineering of PKS and NRPS pathways to design compounds with antibiotic activity.
